MedTrace Logo

European Study of the BrioVAD Heart Pump for Advanced Heart Failure

NCT07252531 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-02

No results posted yet for this study

Summary

This clinical investigation evaluates the safety and clinical performance of the BrioVAD Left Ventricular Assist System in patients with advanced, refractory left ventricular heart failure who require mechanical circulatory support.

Conditions

  • Refractory Heart Failure
  • Cardiovascular Diseases (CVD)

Interventions

DEVICE

LVAD implantation

Implantation of an LVAD in the chest

Sponsors & Collaborators

  • Meditrial SrL

    collaborator INDUSTRY

  • BrioHealth BV

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2027-07-31
Completion
2029-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07252531 on ClinicalTrials.gov